Bone protective effect of sinomenine against monosodium iodoacetate induced knee and hip injury in rat model: an inflammatory pathway.

PURPOSE: Osteoarthritis (OA) is a degenerative joint disease which is categorized via destruction of joint cartilage and it also affects the various joints, especially knees and hips. Sinomenine active phytoconstituents isolated from the stem of Sinomenium acutum and already proof anti-inflammatory effect against the arthritis model of rodent. In this experimental protocol, we scrutinized the anti-osteoarthritis effect of sinomenine against monosodium iodoacetate (MIA) induced OA in rats. METHODS: MIA (3 mg/50 µL) was used for inducing the OA in the rats, and rats received the oral administration of sinomenine (2.5, 5 and 7.5 mg/kg body weight) up to the end of the experimental study (four weeks). The body and organs weight were estimated. Aggrecan, C-terminal cross-linked telopeptide of type II collagen (CTX-II), glycosaminoglycans (GCGs), monocyte chemoattractant protein-1 (MCP-1), Interferon gamma (IFN-γ), antioxidant, inflammatory cytokines, inflammatory mediators and matrix metalloproteinases (MMP) were analyzed. RESULTS: Sinomenine significantly (P < 0.001) boosted the body weight and reduced the heart weight, but the weight of spleen and kidney remain unchanged. Sinomenine significantly (P < 0.001) reduced the level of nitric oxide, MCP-1 and improved the level of aggrecan, IFN-γ and GCGs. Sinomenine remarkably upregulated the level of glutathione, superoxide dismutase and suppressed the level of malonaldehyde. It effectually modulated the level of inflammatory cytokines and inflammatory mediators and significantly (P < 0.001) reduced the level of MMPs, like MMP-1, 2, 3, 9 and 13. CONCLUSIONS: Sinomenine is a beneficial active agent for the treatment of OA disease.

Bone protective effect of sinomenine against monosodium iodoacetate induced knee and hip injury in rat model: an inflammatory pathway

Purpose: Osteoarthritis (OA) is a degenerative joint disease which is categorized via destruction of joint cartilage and it also affects the various joints, especially knees and hips. Sinomenine active phytoconstituents isolated from the stem of Sinomenium acutum and already proof anti-inflammatory effect against the arthritis model of rodent. In this experimental protocol, we scrutinized the anti-osteoarthritis effect of sinomenine against monosodium iodoacetate (MIA) induced OA in rats. Methods: MIA (3 mg/50 µL) was used for inducing the OA in the rats, and rats received the oral administration of sinomenine (2.5, 5 and 7.5 mg/kg body weight) up to the end of the experimental study (four weeks). The body and organs weight were estimated. Aggrecan, C-terminal cross-linked telopeptide of type II collagen (CTX-II), glycosaminoglycans (GCGs), monocyte chemoattractant protein-1 (MCP-1), Interferon gamma (IFN-γ), antioxidant, inflammatory cytokines, inflammatory mediators and matrix metalloproteinases (MMP) were analyzed. Results: Sinomenine significantly (P < 0.001) boosted the body weight and reduced the heart weight, but the weight of spleen and kidney remain unchanged. Sinomenine significantly (P < 0.001) reduced the level of nitric oxide, MCP-1 and improved the level of aggrecan, IFN-γ and GCGs. Sinomenine remarkably upregulated the level of glutathione, superoxide dismutase and suppressed the level of malonaldehyde. It effectually modulated the level of inflammatory cytokines and inflammatory mediators and significantly (P < 0.001) reduced the level of MMPs, like MMP-1, 2, 3, 9 and 13. Conclusions: Sinomenine is a beneficial active agent for the treatment of OA disease.

Slow magnetization dynamics in Co(ii)/Co(iii) triethanolamine/pivalate complexes.

We report the synthesis, structural characterization and a combined computational and experimental study of the magnetic properties of two pivalate cobalt complexes, a mononuclear Co(ii) one and a tetranuclear Co(ii)3Co(iii) mixed valence polynuclear one. The latter shows SMM behaviour revealed under an applied DC field with a thermal barrier of ca. 30 cm-1 competing with direct and Raman relaxation processes. The Orbach thermal barrier can be understood from the doublets energy ladder arising from the anisotropic exchange interaction among ground Seff = 1/2 of each Co(ii) sites. The strong local zero-field splitting of the S = 3/2 Co(ii) states affords these well isolated ground Kramers doublets. DC and AC magnetic susceptibility measurements as well as HF-EPR spectra support this interpretation. CASSCF quantum chemical computations have been also performed in order to aid the overall comprehension of the magnetic behaviour in the reported complexes.

Heterometallic cubane-like {M2Ln2} (M = Ni, Zn; Ln =, Gd, Dy) and {Ni2Y2} aggregates. Synthesis, structures and magnetic properties.

The syntheses, structural determinations and magnetic studies of tetranuclear M(II)Ln(III) complexes (M = Ni, Zn; Ln = Y, Gd, Dy) involving an in situ compartmentalized schiff base ligand HL derived from the condensation of o-vanillin and 2-hydrazinopyridine as main ligand are described. Single-crystal X-ray diffraction reveals that all complexes are closely isostructural, with the central core composed of distorted {M(2)Ln(2)O(4)} cubes of the formulas [Ni(2)Ln(2)(µ(3)-OH)(2)(L)(2)(OAc)(4)(H(2)O)(3.5)](ClO(4))(2)·3H(2)O (Ln = Y 1 and Gd 2), [Ni(2)Dy(2)(µ(3)-OH)(2)(L)(2)(OAc)(5)(EtOH)(H(2)O)(1.5)](ClO(4))·EtOH·H(2)O (3) and [Zn(2)Ln(2)(µ(3)-OH)(2)(L)(2)(OAc)(5)(EtOH)(H(2)O)](ClO(4))·2EtOH·1.5H(2)O (Gd 4 and Dy 5). The Ln(III) ions are linked by two hydroxo bridges and each M(II) ion is also involved in a double phenoxo-hydroxo bridge with the two Ln(III) ions, so that each hydroxo group is triply linked to the two Ln(III) and one M(II) ions. The magnetic properties of all complexes have been investigated. Ni(2)Y(2) (1) has a ferromagnetic Ni(II)Ni(II) interaction. A weak ferromagnetic Ni(II)Ln(III) interaction is observed in the Ni(2)Ln(2) complexes (Ln = Gd 2, Dy 3), along with a weak antiferromagnetic Ln(III)Ln(III) interaction, a D zero-field splitting term for the nickel ion and a ferromagnetic Ni(II)Ni(II) interaction. The isomorphous Zn(2)Ln(2) (Ln = Gd 4, Dy 5) does confirm the presence of a weak antiferromagnetic Ln(III)Ln(III) interaction. The Ni(2)Dy(2) complex (3) does not behave as a SMM, which could result from a subtractive combination of the Dy and Ni anisotropies and an increased transverse anisotropy, leading to large tunnel splittings and quantum tunneling of magnetization. On the other hand, Zn(2)Dy(2) (5) exhibits a possible SMM behavior, where its slow relaxation of magnetization is probably attributed to the presence of the anisotropic Dy(III) ions.

Two novel Dy8 and Dy11 clusters with cubane [Dy4(µ3-OH)4]8+ units exhibiting slow magnetic relaxation behaviour.

Two unique octa- and hendeca-nuclear dysprosium(III) clusters incorporating [Dy(4)(µ(3)-OH)(4)](8+) cubane units have been synthesized with the 1,10-phenanthroline-2,9-dicarbaldehyde dioxime (H(2)phendox) ligand and DyCl(3)·6H(2)O or Dy(OAc)(3)·4H(2)O. They are [Dy(8)(OH)(8)(phendox)(6)(H(2)O)(8)]Cl(2)(OH)(2)·18H(2)O·18MeOH (1) and [Dy(11)(OH)(11)(phendox)(6)(phenda)(3)(OAc)(3)](OH)·40H(2)O·7MeOH (2). Adjacent Dy(8) in 1 or Dy(11) in 2 motifs are packed by off-set π-π interactions of the aromatic rings on phendox(2-) to generate a 3D supramolecular architecture in the honeycomb topology and with 1D or 3D channels along the c-axis. Adsorption research shows that complex 1 has selective adsorption ability for H(2)O over small gas molecules (H(2), N(2), CO(2)). Complex 2 is stable upon the removal of guest molecules and the desolvated compound absorbed a considerable amount of CO(2). Furthermore, the oximes underwent hydrolysis to carboxylic acid and the resulting 1,10-phenanthroline-2,9-dicarboxylate link the dysprosium atoms to form a hendecanuclear cluster of 2. Magnetic studies reveal that both clusters exhibit slow magnetic relaxation behavior, expanding upon the recent reports of the pure 4f type single-molecule magnets (SMMs).